Figure 5.

The therapeutic categories of drugs involved in combinations with respect to the proportion of their targeted interacting pathways. (A) Proportion of the interacting pathways larger than 0.4. (B) Proportion less than or equal to 0.4.

Wang et al. BMC Bioinformatics 2012 13(Suppl 7):S7   doi:10.1186/1471-2105-13-S7-S7